Stock Scorer

Biolargo, Inc. (BLGO)

Biolargo, Inc. reported revenue of 1.2M USD for the quarter ending 30 June 2026, down 55.1% from 2.8M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 1.2M -55.1%
Gross Profit Q2 '26 · ending 30 June 2026 675K -52.5%
Operating Income Q2 '26 · ending 30 June 2026 -3.7M —
Net Income Q2 '26 · ending 30 June 2026 -4M —
Cost of Revenue Q2 '26 · ending 30 June 2026 573K -57.7%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -3.1M —
Free Cash Flow Q1 '18 · ending 31 March 2018 -1M —
Shares Outstanding Q2 '26 · ending 30 June 2026 321M +6.5%
EPS Q2 '26 · ending 30 June 2026 -0.05 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 7.8M-14.9M-15.2M—
20242024-12-31 17.8M-4.3M-4.3M—
20232023-12-31 12.2M-4.6M-4.6M—
20222022-12-31 5.9M-5.4M-5.1M—
20212021-12-31 2.5M-6.8M-6.9M—
20202020-12-31 2.4M-7.6M-9.7M—
20192019-12-31 1.9M-6.7M-11.4M—
20182018-12-31 1.4M-6.4M-10.7M—
20172017-12-31 516K-5.9M-9.5M-4.3M
20162016-12-31 281.1K-4.9M-8.1M—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-301.2M
Q1 '262026-03-311.1M
Q4 '252025-12-31617K
Q3 '252025-09-301.1M
Q2 '252025-06-302.8M
Q1 '252025-03-313.3M
Q4 '242024-12-313.7M
Q3 '242024-09-304.4M
Q2 '242024-06-305M
Q1 '242024-03-314.8M
Q4 '232023-12-314.4M
Q3 '232023-09-302.7M
Q2 '232023-06-301.4M
Q1 '232023-03-313.7M
Q4 '222022-12-312.1M
Q3 '222022-09-301.5M
Q2 '222022-06-301.3M
Q1 '222022-03-31965K
Q4 '212021-12-31788K
Q3 '212021-09-30712K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30675K
Q1 '262026-03-31458K
Q4 '252025-12-31128K
Q3 '252025-09-30372K
Q2 '252025-06-301.4M
Q1 '252025-03-311.5M
Q4 '242024-12-311.8M
Q3 '242024-09-301.7M
Q2 '242024-06-302.1M
Q1 '242024-03-312.2M
Q4 '232023-12-312.1M
Q3 '232023-09-301.4M
Q2 '232023-06-30819K
Q1 '232023-03-311.8M
Q4 '222022-12-31965K
Q3 '222022-09-30752K
Q2 '222022-06-30623K
Q1 '222022-03-31521K
Q4 '212021-12-31323K
Q3 '212021-09-30350K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-3.7M
Q1 '262026-03-31-3.2M
Q4 '252025-12-31-4M
Q3 '252025-09-30-7.2M
Q2 '252025-06-30-1.8M
Q1 '252025-03-31-1.9M
Q4 '242024-12-31-1.6M
Q3 '242024-09-30-1.1M
Q2 '242024-06-30-890K
Q1 '242024-03-31-763K
Q4 '232023-12-31-1M
Q3 '232023-09-30-1.5M
Q2 '232023-06-30-1.6M
Q1 '232023-03-31-477K
Q4 '222022-12-31-1.4M
Q3 '222022-09-30-943K
Q2 '222022-06-30-1.3M
Q1 '222022-03-31-1.7M
Q4 '212021-12-31-1.8M
Q3 '212021-09-30-1.5M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-4M
Q1 '262026-03-31-3.4M
Q4 '252025-12-31-4.1M
Q3 '252025-09-30-7.2M
Q2 '252025-06-30-1.9M
Q1 '252025-03-31-1.9M
Q4 '242024-12-31-1.7M
Q3 '242024-09-30-1.1M
Q2 '242024-06-30-780K
Q1 '242024-03-31-775K
Q4 '232023-12-31-1M
Q3 '232023-09-30-1.5M
Q2 '232023-06-30-1.6M
Q1 '232023-03-31-494K
Q4 '222022-12-31-1.4M
Q3 '222022-09-30-847K
Q2 '222022-06-30-1.3M
Q1 '222022-03-31-1.5M
Q4 '212021-12-31-1.8M
Q3 '212021-09-30-1.4M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30573K
Q1 '262026-03-31657K
Q4 '252025-12-31489K
Q3 '252025-09-30731K
Q2 '252025-06-301.4M
Q1 '252025-03-311.8M
Q4 '242024-12-311.9M
Q3 '242024-09-302.6M
Q2 '242024-06-302.9M
Q1 '242024-03-312.5M
Q4 '232023-12-312.3M
Q3 '232023-09-301.2M
Q2 '232023-06-30627K
Q1 '232023-03-311.9M
Q4 '222022-12-311.1M
Q3 '222022-09-30748K
Q2 '222022-06-30702K
Q1 '222022-03-31444K
Q4 '212021-12-31465K
Q3 '212021-09-30362K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-3.1M
Q1 '262026-03-31-2.9M
Q4 '252025-12-31-1.6M
Q3 '252025-09-30-2.8M
Q2 '252025-06-30-2.1M
Q1 '252025-03-31-1.8M
Q4 '242024-12-31-1.9M
Q3 '242024-09-30-1.6M
Q2 '242024-06-30-151K
Q1 '242024-03-31481K
Q4 '232023-12-31-2K
Q3 '232023-09-30-836K
Q2 '232023-06-30-1.5M
Q1 '232023-03-31-43K
Q4 '222022-12-3141K
Q3 '222022-09-30-939K
Q2 '222022-06-30-724K
Q1 '222022-03-31-1.1M
Q4 '212021-12-31-975K
Q3 '212021-09-30-908K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q1 '182018-03-31-1M
Q4 '112011-12-31-381.9K
Q3 '112011-09-30-333.4K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30321M
Q1 '262026-03-31318.7M
Q3 '252025-09-30309M
Q2 '252025-06-30303.2M
Q1 '252025-03-31301.3M
Q3 '242024-09-30300.5M
Q2 '242024-06-30296.4M
Q1 '242024-03-31294.3M
Q3 '232023-09-30287.9M
Q2 '232023-06-30284.9M
Q1 '232023-03-31280.7M
Q3 '222022-09-30270.7M
Q2 '222022-06-30265.9M
Q1 '222022-03-31260.8M
Q3 '212021-09-30252.9M
Q2 '212021-06-30243.7M
Q1 '212021-03-31233.7M
Q3 '202020-09-30210.2M
Q2 '202020-06-30181.6M
Q1 '202020-03-31168.9M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.05
Q1 '262026-03-31-0.04
Q4 '252025-12-31-0.03
Q3 '252025-09-30-0.03
Q2 '252025-06-30-0.01
Q1 '252025-03-31-0.01
Q4 '242024-12-31-0.01
Q3 '242024-09-30-0.00
Q2 '242024-06-30-0.01
Q1 '242024-03-31-0.01
Q4 '232023-12-31-0.01
Q3 '232023-09-30-0.02
Q2 '232023-06-30-0.02
Q1 '232023-03-31-0.02
Q4 '222022-12-31-0.03
Q3 '222022-09-30-0.03
Q2 '222022-06-30-0.04
Q1 '222022-03-31-0.04
Q4 '212021-12-31-0.04
Q3 '212021-09-30-0.04